Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

IGEL Demonstrates The Healthcare Benefits Of Its Thin Client Technology At Smart Healthcare Live
Fast and secure access to patient files whilst on the move will be just one of the benefits IGEL Technology will be demonstrating using thin clients at Smart Healthcare Live in Earls Court, London, from June 9-10. Using IGEL Universal Desktops with integrated smartcard devices, healthcare professionals can securely log-in to any IGEL device and access patient records in under 10 seconds.
generic viagra online
TeraMedica Delivers Enterprise Imaging Interchange Technology Contributing To Meaningful Use Of EMRs To Healthcare Facilities With Sun Microsystems
TeraMedica Healthcare Technology announced, along with partner, Sun Microsystems, that the two companies will be offering a pre-configured solution for viewing and managing clinical images originating from different modalities and providers to bring secure, consistent image sharing to point-of-care.
News of the day
Abraxis Bioscience Completes Enrollment Of Pivotal Phase III Advanced Lung Cancer Study Evaluating Abraxane(R) Vs. Taxol(R)
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, announced that the company has completed patient enrollment of a pivotal, phase III clinical study comparing the company"s chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) with Taxol® (paclitaxel) injection, both in combination with carboplatin, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC). The study, which is being conducted at 111 sites globally, includes 1,050 patients and is being led by principal investigator Dr. Mark Socinski at the University of North Carolina Lineberger Comprehensive Cancer Center. It is one of the largest NSCLC clinical studies to complete enrollment.
Mental Health

Expression Of Myoglobin In Human Cancers

A group led by Dr. Alberto Bardelli at The University of Turin Medical School reports that myoglobin may protect against the stresses of tumor growth. This study can be found in the July 2009 issue of the American Journal of Pathology. Myoglobin plays an important role in muscle cells by both transporting oxygen and preventing cell damage by scavenging free radicals. Tumor cells often survive in hypoxic (low oxygen), high free radical environments, despite these stresses on tumor growth. Flonta et al hypothesized that certain cancers may express myoglobin to survive the conditions associated with tumor growth. Indeed, human epithelial tumors, including breast, lung, ovary, and colon carcinomas, expressed high levels of myoglobin at early stages of development. In addition, myoglobin was induced in cell lines subjected to hypoxia, oxidative stress, and mitogenic stimulation. Myoglobin expression in carcinomas may therefore protect against the stresses of tumor growth. Dr. Bardelli and colleagues postulate that "should myoglobin prove to play a causative role in tumor progression, ò€¦ it is tempting to speculate that targeting one or more of its multiple functions by pharmacological agents or more advanced molecular tools could represent a novel therapeutic strategy in oncology." Flonta SE, Arena S, Pisacane A, Michieli P, Bardelli A: Expression and Functional Regulation of Myoglobin in Epithelial Cancers. Am J Pathol 2009, 174: 2611-2616 Angela Colmone American Journal of Pathology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009